Phase
Condition
Diabetes And Hypertension
Diet And Nutrition
Diabetic Vitreous Hemorrhage
Treatment
DSF1
Standard of Care (SOC)
DSF2
Clinical Study ID
Ages 21-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Participants are eligible to be included in the study only if all of the following criteria apply:
Has any of the following types of diabetes:
Type 1 diabetes
Type 2 diabetes
Prediabetes
Has Malnutrition Universal Screening Tool (MUST) score of ≥ 1
Serum albumin less than 3.5 g/dL
Energy or protein intake less than recommended
BMI less than 30.0 kg/m2
Either a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to the study
Female of childbearing potential to use an effective method of birth control
Chronic medication type and dose to be constant and maintained throughout the study
Willing to follow the protocol throughout the study
At least a two-week washout period between the completion of a previous research study and start in current study
Willing to refrain from taking non-study diabetes-specific formula over the course of the study.
Exclusion Criteria
Participants are excluded from the study if any of the following criteria apply:
Has a screening HbA1c level less than 5.7% or ≥ 10%
Has a current infection, inpatient surgery or received systemic corticosteroid treatment in the last 3 months; or received antibiotics in the last 3 weeks
Has active malignancy within the last 5 years
Has significant cardiovascular event within 6 months prior to the study or history of congestive heart failure
Has end-stage organ failure or is post-organ transplant
Has current or history of renal disease or on dialysis or severe gastroparesis
Has current hepatic disease
Has a recent acute infection, physiologic stress or trauma within 1 month prior to the study
Has had bariatric surgery including gastric balloon; history of gastrointestinal disease or intestinal surgery that can interfere with consumption or digestion or absorption of study product
Has a chronic, contagious, infectious disease
Has eating disorder, severe dementia or delirium, history of significant neurological or psychiatric disorder, alcoholism, substance abuse or other conditions that may interfere with study product consumption or compliance with study procedures
Taking any herbals, dietary supplements or medications during the past 4 weeks prior to the study
Using diabetes-specific formula(s) or oral nutritional supplement formula(s) in more than one eating occasion per week within the past 3 months
Has clotting or bleeding disorders
Has blood or blood-related diseases
Has received blood transfusion within the last 3 weeks
Has allergy or intolerance to the study product
Anticipated poor compliance to the study as assessed by the Investigator
Participates in another study that has not been approved as a concomitant study by Abbott Nutrition
Study Design
Study Description
Connect with a study center
Chung Shan Medical University
Taichung, 40201
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.